BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6431492)

  • 21. The difficult doctor? Characteristics of physicians who report frustration with patients: an analysis of survey data.
    Krebs EE; Garrett JM; Konrad TR
    BMC Health Serv Res; 2006 Oct; 6():128. PubMed ID: 17026762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes and practices about postmenopausal hormone therapy among female gynecologists in Brazil.
    Filho AS; Soares Júnior JM; Arkader J; Maciel GA; Baracat EC
    Maturitas; 2005 Jun; 51(2):146-53. PubMed ID: 15917155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attitudes of Norwegian general practitioners to prescription of estrogens 1990-92].
    Hunskår S; Hannestad YS; Backe B; Matheson I
    Tidsskr Nor Laegeforen; 1994 Aug; 114(18):2095-8. PubMed ID: 7992263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer screening guideline preference surveys: physicians' perceptions of the American Cancer Society.
    Hamblin J; Connor PD
    Tenn Med; 1998 Jan; 91(1):17-20. PubMed ID: 9439181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief report: attitudes toward hormone therapy after the Women's Health Initiative: a comparison of internists and gynecologists.
    Brett AS; Carney PI; McKeown RE
    J Gen Intern Med; 2005 May; 20(5):416-8. PubMed ID: 15963163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teaching medical students in community-based practices: a national survey of generalist physicians.
    Vinson DC; Paden C; Devera-Sales A; Marshall B; Waters EC
    J Fam Pract; 1997 Dec; 45(6):487-94. PubMed ID: 9420584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy.
    Hovi SL; Karttunen T; Karro H; Hemminki E
    Maturitas; 2004 Oct; 49(2):107-13. PubMed ID: 15474754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician-identified barriers to intimate partner violence screening.
    Jaffee KD; Epling JW; Grant W; Ghandour RM; Callendar E
    J Womens Health (Larchmt); 2005 Oct; 14(8):713-20. PubMed ID: 16232103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives.
    Sulak PJ; Buckley T; Kuehl TJ
    Contraception; 2006 Jan; 73(1):41-5. PubMed ID: 16371293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
    Crandall C
    J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco.
    Potter M; Schafer S; Gonzalez-Mendez E; Gjeltema K; Lopez A; Wu J; Pedrin R; Cozen M; Wilson R; Thom D; Croughan-Minihane M
    J Fam Pract; 2001 Feb; 50(2):145-51. PubMed ID: 11219563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies.
    Keenan NL; Mark S; Fugh-Berman A; Browne D; Kaczmarczyk J; Hunter C
    Menopause; 2003; 10(6):507-15. PubMed ID: 14627858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists.
    Greendale GA; Carlson KJ; Schiff I
    J Gen Intern Med; 1990; 5(6):464-9. PubMed ID: 2266426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing of FDA-approved and compounded hormone therapy differs by specialty.
    Constantine GD; Archer DF; Graham S; Bernick BA; Mirkin S
    Menopause; 2016 Oct; 23(10):1075-82. PubMed ID: 27648594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicians' views on hormone therapy around and after menopause.
    Hemminki E; Topo P; Malin M; Kangas I
    Maturitas; 1993 May; 16(3):163-73. PubMed ID: 8515716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause.
    Kaplan B; Aschkenazi-Steinberg S; Yogev Y; Nahum R; Sulkes J; Phisher M
    Menopause; 2002; 9(5):354-9. PubMed ID: 12218724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey.
    Yokoyama Y; Ito K; Takamatsu K; Takehara K; Nakanishi T; Harano K; Watari H; Susumu N; Aoki D; Saito T;
    Int J Clin Oncol; 2015 Oct; 20(5):997-1004. PubMed ID: 25744579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy in patients with endometrial cancer: prescription attitude of Belgian gynecologists.
    Rozenberg S; Vasquez JB
    Maturitas; 2000 May; 35(2):125-8. PubMed ID: 10924838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.